Biobot Analytics
Biobot Analytics is a wastewater intelligence company that measures human health signals in sewage to deliver population-level public health data. Founded out of MIT in 2017, Biobot analyzes wastewater samples for pathogens (SARS-CoV-2, influenza, RSV, mpox), substances (opioids and other drugs), and other biomarkers, turning them into de-identified, community-scale intelligence. It serves federal government, state and local government, pharmaceutical and life-science organizations, healthcare systems, and wastewater treatment plants, who access results and dashboards through Biobot's customer data-exploration platform. Biobot is a venture-backed company in the DCVC portfolio. This profile currently exposes no public developer API; Biobot delivers data via reports and a login-gated platform rather than an open API program.
Biobot Analytics is profiled on the APIs.io network. Tagged areas include Company, Wastewater, Epidemiology, Public Health, and Data Intelligence.
Biobot Analytics’ developer surface includes engineering blog and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API